ESMO – European Society for Medical Oncology shared a post on LinkedIn:
“ESMOImmuno25: Share your new data in a platform where early discoveries meet clinical implementation – accelerating progress from bench to bedside.
Submission deadline: 30 September 2025
Why submit?
- Global exposure: Present your research to an international audience of experts and innovators.
- Networking: Connect with leading scientists, clinicians, and industry professionals.
- Professional recognition: Enhance your profile and gain valuable feedback. Publication opportunity.
Accepted abstracts will be published in the ESMO Immuno-Oncology Congress 2025 Abstract Book, a supplement to the official ESMO journal, ESMO IOTECH.
Experience London: Immerse yourself in a city known for its scientific excellence and cultural richness.”
Read more about ESMO Immuno Oncology Congress 2025 on OncoDaily.